WHO ICTRP trial
Evaluation of treatment with progesterone in controlled ovarian stimulation for…
JPRN-UMIN000035469 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000035469 |
|---|---|
| Public title | Evaluation of treatment with progesterone in controlled ovarian stimulation for patients undergoing IVF/ICSI cycles to prevent ovulation: a randomized clinical trial |
| Scientific title | Evaluation of treatment with progesterone in controlled ovarian stimulation for patients undergoing IVF/ICSI cycles to prevent ovulation: a randomized clinical trial - MPA study |
| Primary sponsor | Hanabusa Womens' clinic |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Infertility |
| Interventions | 10mg of MPA (medroxyprogesterone) oral intake daily for 10 days 0.25mg of GnRHantagonist injection subcutaneously daily for 1 to 3 days |
| Registration date | Jul 1, 2019 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: